A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma
A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma
Recruiting · NCT07086105 · Registry updated 2026-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate Adze1.C in Participants With Metastatic Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, metastatic melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2026-07-08 | NCT07086105 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adze Biotechnology Australia Pty Ltd | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Monash Health | Clayton | Australia | 74 |
| Tasman Oncology Research | Southport | Australia | 8 |
| The Queen Elizabeth Hospital | Adelaide | Australia | 6 |